Acquisition Opportunity Clariness has recently been acquired by SubjectWell, creating a global, full-service patient recruitment platform. This signals a potential cross-sell of ClinLife capabilities or integration services to existing SubjectWell clients and Boehringer Ingelheim partnerships that could expand reach and scale.

Leadership Growth New CEO Jim Corrigan appointed in December 2025 indicates a growth-focused strategy. This presents an opening to align with executive leadership on strategic initiatives such as site contact center expansion, enhanced enrollment efficiency, and new market entries.

Expansion Momentum Track record of site support enhancements like the Site Contact Center launched in 2024 and multi-country expansion with Boehringer Ingelheim. Use this to propose scalable enrollment solutions, regional enrollment optimization, and expanded feasibility studies in Europe and other regions.

Security & Compliance Clariness prioritizes data security with cloud security partnerships and a Privacy Pledge for the ClinLife portal. Position privacy-first enrollment and compliant data handling as differentiators when bidding for trials with stringent regulatory requirements.

Global Reach Operational in over 50 countries with a ClinLife community of millions of patients. Offer value through cross-border recruitment capabilities, diverse patient populations, and rapid global site activation to accelerate trial timelines for sponsors seeking broad geographic coverage.